MedTrace Logo

Influence of Pregnenolone on Exposure Therapy in Obsessive-compulsive Disorder

NCT01949753 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2017-08-03

No results posted yet for this study

Summary

Characterization of the influence of pregnenolone vs. placebo on subjective distress and autonomic functioning during cognitive-behavioral exposure therapy in patients with obsessive-compulsive disorder.

Conditions

  • Obsessive-compulsive Disorder (OCD)

Interventions

BEHAVIORAL

Exposure therapy with pharmacological facilitation

Exposure with response prevention and pharmacological facilitation

BEHAVIORAL

Exposure therapy

Exposure with response prevention without pharmacological facilitation

Sponsors & Collaborators

  • Universitätsklinikum Hamburg-Eppendorf

    lead OTHER

Principal Investigators

  • Michael Kellner, MD, PhD · Universitätsklinikum Hamburg-Eppendorf

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2017-12-31
Completion
2018-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01949753 on ClinicalTrials.gov